? Please tell us about your preferences so that we can bring you more of what you want from Nephrology Times!
此处无法显示此内容
在领英 APP 中访问此内容等
关于我们
Nephrology Times delivers the latest news in nephrological treatments and technologies with the goal of better informing care decisions and improving patient outcomes.
- 网站
-
https://www.docwirenews.com/page/nephrology-times
Nephrology Times的外部链接
- 所属行业
- 互联网出版
- 规模
- 2-10 人
- 类型
- 合营企业
动态
-
"...atacicept offers a potentially safe, long-term, disease-modifying treatment for IgAN." #nephrology #kidneydisease #kidneywk #iganephropathy
-
Dr. Carla Nester spoke with Neph Times about two trials of C3G therapies presented at #KidneyWk. #kidneydisease #nephrology
Phase 3 Trials of C3G Therapies | Docwire News
docwirenews.com
-
?? ?? ?? Looking for something to do over the long, upcoming Thanksgiving weekend? How about catching up with our #KidneyWk conference coverage, which includes interviews conducted onsite in San Diego? ?? ?? ?? #nephrology #kidney
ASN Kidney Week 2024 | Docwire News
docwirenews.com
-
??? If you haven't signed up for our e-newsletters, what are you waiting for? Get the latest updates on nephrology topics delivered right to your inbox. #kidney #nephrology
Subscribe | Docwire News
docwirenews.com
-
Melissa Little joined us at #KidneyWk for a chat about her research and the possibilities of #kidney regeneration. #nephrology
Melissa Little on Kidney Regeneration | Docwire News
docwirenews.com
-
Researchers used a biopsy registry to study outcomes of adult #IgAN at the population level. #iganephropathy #kidneywk #nephrology #kidneydisease
Population-Level Study of IgAN Using a Biopsy Registry | Docwire News
docwirenews.com
-
?? Have you seen our interviews from ASN #KidneyWk 2024? Don't miss this conversation with Dr. Mohamad Hussain, who presented results of a phase 3 trial of the acellular tissue engineered vessel (ATEV) in AV access for patients with ESRD. #nephrology #kidneydisease
Acellular Tissue Engineered Vessel for Hemodialysis Access | Docwire News
docwirenews.com
-
In a high-impact oral session at #KidneyWk, Dr. Heerspink shared results of a study examining the effects of semaglutide in patients with overweight/obesity and albuminuria CKD without diabetes. #KidneyWk #nephrology #kidneydisease #obesity #semaglutide
Examining the Safety and Efficacy of Semaglutide in Nondiabetic CKD | Docwire News
docwirenews.com
-
??? You can now find us on Bluesky, in addition to LinkedIn, X, and Facebook! https://lnkd.in/gPUH49m5
Nephrology Times (@nephtimes.bsky.social)
bsky.app